eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Documenthome » Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data; Availability

Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data; Availability

Document ID: FDA-2009-N-0247-0281

Comments

Total: 10
varley dias sousa - Comment
Posted : 10/13/2011     ID ：FDA-2009-N-0247-0283     Agency : FDA

Dec 02,2011 11:59 PM ET
Society of Chemical Manufacturers and Affiliates (SOCMA) - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0287     Agency : FDA

Dec 02,2011 11:59 PM ET
Healthcare Distribution Management Association (HDMA) - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0289     Agency : FDA

Dec 02,2011 11:59 PM ET
Combination Products Coalition - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0291     Agency : FDA

Dec 02,2011 11:59 PM ET
The Humane Society of the United States - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0292     Agency : FDA

Dec 02,2011 11:59 PM ET
Cook Group Incorporated - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0293     Agency : FDA

Dec 02,2011 11:59 PM ET
The Johns Hopkins Center for a Livable Future - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0295     Agency : FDA

Dec 02,2011 11:59 PM ET
Biotechnology Industry Organization (BIO) - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0297     Agency : FDA

Dec 02,2011 11:59 PM ET
Novartis Pharmaceuticals Corporation - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0298     Agency : FDA

Dec 02,2011 11:59 PM ET
GlaxoSmithKline - Comment
Posted : 12/15/2011     ID ：FDA-2009-N-0247-0299     Agency : FDA

Dec 02,2011 11:59 PM ET